Regulation of B cell proliferation and differentiation by retinoic acid

Seminars in Immunology

Volumn 21, Issue 1, 2009, Pages 36-41

  Ertesvåg, Åse ^a   Naderi, Soheil ^a   Blomhoff, Heidi Kiil ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

B cells; Differentiation; Proliferation; Retinoic acid

Indexed keywords

ALPHA INTERFERON; ANTIGEN; DEXAMETHASONE; IMMUNOGLOBULIN A; RETINOIC ACID;

ANTIBODY RESPONSE; B LYMPHOCYTE; CANCER CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; COMMON VARIABLE IMMUNODEFICIENCY; DRUG MECHANISM; GASTROINTESTINAL MUCOSA; HUMAN; HYBRIDOMA; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOLOGY; IMMUNOREGULATION; IN VIVO STUDY; INFECTION; LYMPHOPROLIFERATIVE DISEASE; MANTLE CELL LYMPHOMA; MOLECULAR MECHANICS; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NONHUMAN; OVERALL SURVIVAL; REVIEW; T LYMPHOCYTE; VIRUS INFECTION; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINES; HUMANS; TRETINOIN; VITAMIN A;

EID: 56249130743     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2008.06.005     Document Type: Review

References (106)

1. Semba R.D. Vitamin A, immunity and infections. Clin Infect Dis 19 (1994) 489-499
2. Semba R.D. The role of vitamin A and related retinoids in immune function. Nutr Rev 56 (1998) 38-48
3. Stephensen C.B. Vitamin A, infection and immune function. Ann Rev Nutr 21 (2001) 167-192
4. Ross A.C. Vitamin A supplementation and retinoic acid treatment in the regulation of antibody responses in vivo. Vitamin Hormones 75 (2007) 197-221
5. West Jr. K.P. Vitamin A deficiency. Its epidemiology and relation to child mortality and morbidity. In: Blomhoff R. (Ed). Vitamin A in health and disease (1994), Marcel Dekker Inc., New York 585-614
6. Semba R.D., and Vitamin. A and immunity to viral, bacterial and protozoan infections. Proc Nutr Soc 57 (1999) 719-727
7. Barclay A.J.G., Foster A., and Sommer A. Vitamin A supplements and mortality related to measles: a randomized clinical trial. Br Med J 294 (1987) 294-296
8. Ogaro F.O., Orinda V.A., Onyango F.E., and Black R.E. Effect of vitamin A on diarrhoel and respiratpry complications of measles. Trop Geogr Med 45 (1993) 283-286
9. Hussey G.D., and Klein M. A randomized, controlled trial of vitamin A in children with severe measles. New Eng J Med 323 (1990) 160-164
10. Semba R.D., and Vitamin. A as "anti-infective" therapy. J Nutr 129 (1999) 783-791
11. Villamor E., and Fawzi W.W. Effects of vitamin A supplementation on immune responses and correlation with clinical outcome. Clin Microbio Rev 18 (2005) 446-464
12. Long K.Z., Rosado J.L., DuPont H.L., Hertzmark E., and Santos J.I. Supplementation with vitamin A reduces water diarrhoea and respiratory infections in Mexican children. Br J Nutr 97 (2007) 37-43
13. Dennert G. Retinoids and the immune system. Retinoids 2 (1984) 373-390
14. Blomhoff H.K., and Smeland E.B. Role of retinoids in normal hematopoiesis and the immune system. In: Blomhoff R. (Ed). Vitamin A in health and disease (1994), Marcel Dekker Inc., New York 451-484
15. Ross A.C., and Hämmerling U.G. Retinoids and the immune system. In: Sporn M.B., Roberts A.B., and Goodman D.S. (Eds). The retinoids: biology, chemistry and medicine (1994), Raven Press Ltd., New York 521-543
16. Buck J., Ritter G., Dannecker L., Katta A., Cohen S.L., Chait B.T., et al. Retinol is essential for growth of activated human B cells. J Exp Med 171 (1990) 1613-1624
17. Buck J., Derguini F., Levi E., Nakanishi K., and Hämmerling U. Intracellualr signaling by 14-hydroxy-4,14-Retroretinol. Science 254 (1991) 1654-1656
18. Buck J., Myc A., Garbe A., and Cathomas G. Differences in the action and metabolisms between retinol and retinoic acid in B lymphocytes. J Cell Biol 115 (1991) 85-89
19. Blomhoff R., Green M.H., Berg T., and Norum K.R. Transport and storage of vitamin A. Science 250 (1990) 399-404
20. Blomhoff R., and Blomhoff H.K. Overview of retinoid metabolism and function. J Neurobiol 66 (2006) 606-630
21. Sklan D., Trifon S., Kedar O., Vaisman N., and Berner Y. Retinoid metabolism in human leukocytes. Br J Nutr 73 (1995) 889-895
22. Iwata M., Hirakiyama A., Eshima Y., Kagechika H., Kato C., and Song S.-Y. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21 (2004) 527-538
23. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 10 (1996) 940-954
24. Lømo J., Smeland E.B., Ulven S., Natarajan V., Blomhoff R., Gandhi U., et al. RAR-, not RXR-ligands inhibit cell activation and prevent apoptosis in B-lymphocytes. J Cell Physiol 175 (1998) 68-77
25. Kastner P., Mark M., and Chambon P. Nonsteroid nuclear receptors: what are gentic studies telling us about their role in real life?. Cell 83 (1995) 859-869
26. Kupitza G., Hulla W., Harant H., Dittrich E., Kallay E., Huber H., et al. Retinoic acid induced death of ovarian carcinoma cells correlates with c-myc stimulation. Int J Cancer 61 (1995) 649-657
27. Konta T., Xu Q., Furusu A., Nakayama K., and Kitamura M. Selective roles of retinoic acid receptor and retinoid × receptor in the suppression of apoptosis by all-trans retinoic acid. J Biol Chem 276 (2001) 12697-12701
28. Balmer J.E., and Blomhoff R. Gene expression regulation by retinoic acid. J Lipid Res 43 (2002) 1773-1808
29. Hoyos B., Imam A., Chua R., Swenson C., Tong G.X., Levi E., et al. The cysteine-rich regions of the regulatory domains of Raf and protein kinase C as retinoid receptors. J Exp Med 192 (2000) 835-845
30. Imam A., Hoyos B., Swenson C., Levi E., Chua R., Viriya E., et al. Retinoids as ligands and coactivators of protein kinase alpha. FASEB J 15 (2001) 28-30
31. Hoyos B., Jiang S., and Hämmerling U. Location and functional significance of retinol-binding sites on the serine threonine kinase c-Raf. J Biol Chem 280 (2005) 6782-6788
32. Canro M.P. Peripheral B-cell maturation: the intersection of selection and homeostasis. Immunol Rev 197 (2004) 89-101
33. Thomas M.D., Srivastava B., and Allman D. Regulaiton of peripheral B cell maturation. Cell Immunol 239 (2006) 92-102
34. Monroe J.G., and Dorshkind K. Fate decisions regulating bone marrow and peripheral B lymphocyte development. Adv Immunol 95 (2007) 2-47
35. Smith S.M., and Hayes C.E. Contrasting impairments in IgM and IgG responses of vitamin A-deficient mice. Proc Natl Acad Sci USA 84 (1987) 5878-5882
36. Semba R.D., Muhilal, Scott A.L., Natadisastra G., Wirasasmita S., Mele L., et al. Depressed immune response to tetanus in children with vitamin A deficiency. J Nutr 122 (1992) 101-107
37. Pasatiempo A.M.G., Bowman T.A., Taylor C.E., and Ross A.C. Vitamin A depletion and repletion: effects on antibody response to capsular polysaccharide of Streptococcus pneumoniae, type III. Am J Lin Nutr 49 (1989) 501-510
38. Aurora D., and Ross A.C. Antibody response against tetanus toxoid is enhanced by lipopolysaccharide or tumor necrosis factor-alpha in vitamin A-sufficient and-deficient rats. Am J Clin Nutr 59 (1994) 922-928
39. Ross A.C. Vitamin A deficiency and retinoid repletion regulate the antibody response to bacterial antigens and the maintenance of natural killer cells. Clin Immunol Immunopathol 80 (1996) S36-72
40. Carman J.A., Pond L., Nashold F., Wassom D.L., and Hayes C.E. Immunity to Trichinella spiralis infection in vitamin A deficeint mice. J Exp Med 175 (1992) 111-120
41. Wiedermann U., Hanson LÅ, Kahu H., and Dahlgren U.I. Aberrant T-cell function in vitro and impaired T-cell dependent antibody response in vivo in vitamin A-deficient rats. Immunol 80 (1993) 581-586
42. Cantorna M.T., Nashold F.E., and Hayes C.E. In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J Immunol 152 (1994) 1515-1522
43. Rühl R., Garcia A., Schweigert F.J., and Worm M. Modulation of cytokine production by low and high retinoid diets in ovalbumin-sensitized mice. Int J Vit Nutr Res 74 (2004) 279-284
44. Iwata M., Eshima Y., and Kagechika H. Retinoic acids exort direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int Immunol 15 (2003) 1017-1025
45. Yu S., Xia M., Xu W., Chu Y., Wang Y., and Xiong S. All-trans retinoic acid biasis immune responses induced by DNA vaccine in a Th2 direction. Vaccine 23 (2005) 5160-5167
46. Stephensen C.B., Jiang X., and Freytag T. Vitamin A deficiency increases the in vivo development of IL-10-positive Th2 cells and decreases the development of Th1 cells in mice. J Nutr 134 (2004) 2660-2666
47. Ertesvag A., Engedal N., Naderi S., and Blomhoff H.K. Retinoic acid stimulates the cell cycle machinery in normal T cells: involvement of retinoic acid receptor-mediated IL-2 secretion. J Immunol 169 (2002) 5555-5563
48. Engedal N., Ertesvag A., and Blomhoff H.K. Survival of activated human T lymphocytes is promoted by retinoic acid via induction of IL-2. Int Immunol 16 (2004) 443-453
49. Sidell N., Kummer U., Aframian D., and Thierfelder S. Retinoid regulation of interleukin-2 receptors on human T cells. Cell Immunol 179 (1997) 116-125
50. Cherian T., Varkki S., Raghupathy P., Ratnam S., and Chandra R.K. Effect of vitamin A supplementation on the immune response to measles vaccination. Vaccine 21 (2003) 2418-2420
51. Benn C.S., Balde A., George E., Kidd M., Whittle H., Lisse I.M., et al. Effect of vitamin A supplementation on measles-specific antibody levels in Guinea-Bissau. Lancet 259 (2002) 1313-1314
52. NMWR Morb Mortal Wkly Rep 2007; 56:1237-41.
53. Schuster G.U., Kenyon N.J., and Stephensen C.B. Vitamin A deficiency decreases and high dietary vitamin A increases disease severity in the mouse modell of asthma. J Immunol 180 (2008) 1834-1842
54. 2+ currents and cell proliferation in a B-lymphocyte cell line. J Cell Physiol 135 (1988) 317-323
55. Blomhoff H., Smeland E.B., Erikstein B., Rasmussen A., Skrede B., Skjønsberg C., et al. Vitamin A is a key regulator of cell growth, cytokine production and differentiation in normal B cells. J Biol Chem 267 (1992) 23988-23992
56. Naderi S., and Blomhoff H.K. Retinoic acid prevents phosphorylation of pRB in normal human B lymphocytes: regulation of cyclin E, cyclin A and p21cip. Blood 94 (2000) 1348-1358
57. Fahlman C., Jacobsen S.E., Smeland E.B., Lømo J., Næss C.E., Funderud S., et al. All-trans- and 9-cis-retinoic acid inhibits growth of normal human and murine B cell precursors. J Immunol 155 (1995) 58-65
58. Chen Q., and Ross A.C. Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and Cd38-stimulated splenic B cells. Proc Natl Acad Sci USA 102 (2005) 14142-14149
59. Chen Q., and Ross A.C. Retinoic acid promotes mouse splenic B cell surface IgG expression and maturation stimulated by CD40 and IL-4. Cell Immunol 249 (2007) 37-45
60. Morikawa K., and Nonaka M. All-trans-retinoic acid accelerates the differentiation of human B lymphocytes maturating into plasma cells. Int Immnopharm 5 (2005) 1830-1838
61. Scheffel F., Heine G., Henz B.M., and Worm M. Retinoic acid inhibits CD40 plus IL-4 mediated IgE production through alternations of sCD23, sCD54 and IL-6 production. Inflamm Res 54 (2005) 113-118
62. Chen X., Esplin B.L., Garrett K.P., Welner R.S., Webb C.F., and Kincade P.W. Retinoids accelerate B lineage lymphoid differentiation. J Immunol 180 (2008) 138-145
63. Tangye S.G., Avery D.T., Deenick E.K., and Hodgkin P.D. Intrinsic differences in the proliferation of naïve and memory human B cells as mechanisms for enhanced secondary immune responses. J Immunol 170 (2003) 686-694
64. Agematsu K., Hokibara S., Nagumo H., and Komiyama A. CD27: a memory B-cell marker. Immunol Today 21 (2000) 204-206
65. Bernasconi N.L., Onai N., and Lanzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLRp by BcR triggering in naïve B cells and constitutive expression in memory B cells. Blood 101 (2003) 4500-4504
66. Krieg A.M., Yi A.K., matson S., Waldschmidt T.J., Bishop G.A., and Teasdale R. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549
67. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
68. Ertesvag A., Aasheim H.C., Naderi S., and Blomhoff H.K. Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38MAPK. Blood 109 (2007) 3865-3872
69. Bernasconi N.L., Traggiai E., and Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human meory B cells. Science 298 (2002) 2199-2202
70. Traggiai E., Puzone R., and Lanzavecchia A. Antigen dependent and independent mechanisms that sustain serum antibody levels. Vaccine 21 (2003) S35-S37
71. Wiedermann U., Hanson L.A., Holmgren J., Kahu H., and Dahlgren U.I. Impaired mucosal antibody response to cholera toxin in vitamin A-deficient rats immunized with oral cholera toxin. Infect Immun 61 (1993) 3952-3957
72. Nikawa T., Odahara K., Koizumi H., Kido Y., Teshima S., Rokutan K., et al. Vitamin A prevents the decline in IgA and Th2 cytokine levels in small intestinal mucosa of protein-malnourished mice. J Nutr 129 (1999) 934-941
73. Tokuyama H., and Tokuyama Y. Retinoids as Ig isotype-switch modulators. The role of retinoids in directing isotype switching to IgA and IgG1 (IgE) in association with IL-4 and IL-5. Cell Immunol 170 (1996) 230-234
74. Tokuyama H., and Tokuyama Y. The regulatory effects of all-trans retinoic acid on isotype switching: retinoic acid induces IgA switch rearrangement in cooperation with IL-5 and inhibits IGG1 switching. Cell Immunol 192 (1999) 41-47
75. Nikawa T., Ikemoto M., Kano M., Tokuoka K., Hirasaka K., Uehara S., et al. Impaired vitamin A-mediated mucosal IgA response in IL-5 receptor-knockout mice. Biochem Biophys Res Commun 285 (2001) 546-549
76. Mora J.R., Iwata M., Eksteen B., Song S.Y., Junt T., Senman B., et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 314 (2006) 1157-1160
77. Tezuka H., Abe Y., Iwata M., Takeuchi H., Ishikawa H., Matsushita M., et al. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature 448 (2007) 929-933
78. Zou F., Liu Y., Liu L., Wu K., Wei W., Zhu Y., et al. Retinoic acid activates human inducible nitric oxide synthase gene through binding of RARα/RXRα heterodimer to a novel retinoic acid response element in the promoter. Biochem Biophys Res Com 355 (2007) 494-500
79. Saurer L., McCullough K.C., and Summerfield A. In vitro induction of mucosa-type dendritic cells by all-trans retinoic acid. J Immunol 179 (2007) 3504-3514
80. Cunningham-Rundles C., and Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patiens. Clin Immunol 92 (1999) 34-48
81. Chapel H., Geha R., and Rosen F. Primary immunodeficiency diseases: an update. Clin Exp Immunol 32 (2003) 9-15
82. Aukrust P., Müller F., Ueland T., Svardal A.M., Berge R.K., and Frøland S.S. Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses. Eur J Clin Invest 30 (2000) 252-259
83. Sherr E., Adelman D.C., Saxon A., Gilly M., Wall R., and Sidell N. Retinoic acid induces the differentiation of B cell hybridomas from patients with common variable immunodeficiency. J Exp Med 168 (1988) 55-71
84. Cunningham-Rundles C., Radigan L., Knight A., Zhang L., Bauer L., and Nakazawa A. TLR9 activation is defective in common variable immune deficiency. J Immunol 176 (2006) 1978-1987
85. Plebani A., Lougaris V., Soresina A., Meini A., Zunino F., Losi C.G., et al. A novel immunodeficiency characterized by the exclusive presence of translational B cells unresponsive to CpG. Immunology 121 (2007) 183-188
86. Rezk S.A., and Weiss L.M. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol 38 (2007) 1293-1304
87. Klein G. Epstin-Barr virus (EBV)-induced transformation of human lymphoid cells and immunosurveillance against lymphoma development. Ann Immunol 124 (1973) 391-405
88. Sugden B. Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro. Rev Infect Dis 4 (1982) 1048-1061
89. Nalesnik M.A., Jaffe R., Starzi T.E., Demetris A.J., Porter K., Burnham J.A., et al. The pathology of post-transplant lymphoproliferative disorders occuring in the setting of cyclospoine A-prednisone immunosuppression. Am J Pathol 133 (1988) 178-192
90. Young L., Alfieri C., Hennessy K., Evans H., O'Hara C., Anderson K.C., et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321 (1989) 1080-1085
91. Pomponi F., Cariati R., Zancai P., de Paoli P., Rizzo S., Tedeschi R.M., et al. retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes. Blood 88 (1996) 3147-3159
92. Cariati R., Zancai P., Quaia M., Cutrona G., Giannini F., Rizzo S., et al. Retinoic acid induces persistent, RARα-mediated anti-proliferative responses in Epstein-Barr virus-immortalized B lymphoblasts carrying and activated c-myc oncogene but not in Burkitt's lymphoma cell lines. Int J Cancer 86 (2000) 375-384
93. skp2 and Cks1 proteins. Oncogene 24 (2005) 2483-2494
94. Bonnefoix T., Gressin R., Jacrot M., Perron P., Swiercz P., Chaffanjon P., et al. Growth modulation of freshly isolated non-Hodgkin's B lymphoma cells induced by various cytokines and all-trans-retinoic acid. Leuk Lymphoma 25 (1997) 169-178
95. Sundaresan A., Claypool K., Mehta K., Lopez-Berestein G., Cabanillas F., and Ford Jr. R.J. Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B cell lymphomas. Cell Growth Differ 8 (1977) 1071-1082
96. Niitsu N., Higashihara M., and Honma Y. Human B- cell lymphoma cell lines are highly sensitive to apoptosis induced by all-trans retinoic acid and interferon-g. Leuk Res 26 (2002) 745-755
97. Guidoboni M., Zancai P., Cariati R., Rizzo S., Col J.D., Pavan A., et al. Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma. Cancer Res 65 (2005) 587-595
98. Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., et al. Autokrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332 (1988) 83-85
99. Klein B., Zhang X.-G., Jourdan M., Content J., Houssiau F., Aarden L., et al. Paracrine rather than autokrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73 (1989) 517-526
100. Anderson K.C., Jones R.M., Morimoto C., Leavitt P., and Barut B.A. Response patterns of purified myeloma cells to hematopoietic growth factors. Blood 73 (1989) 1915-1924
101. Barlogie B., Schaughnessy J., Tricot G., Jacobsen J., Zangari M., Anaissie E., et al. Treatment of multiple myeloma. Blood 103 (2004) 20-36
102. Ogata A., Nishimoto N., Shima Y., Yoshizaki K., and Kishimoto T. Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction. Blood 84 (1994) 3040-3046
103. WAF1. Blood 94 (1999) 251-259
104. Otsuki T., Sakaguchi H., Hatayama T., Wu P., Takata A., and Hyodoh F. effects of all-trans retinopic acid (ATRA) on human myeloma cells. Leuk Lymphoma 44 (2003) 1651-1656
105. Koskela K., Pelliniemi T.T., Pulkki K., and Remes K. Treatment of multiple myeloma with all-trans retinoic acid alone and in combination with chemotherapy: a phase I/II trial. Leuk Lymphoma 45 (2004) 749-754
106. Avilés A., Neri N., Nambo M.J., Cleto S., Castañeda C., González M., et al. Novel therapy in multiple myeloma. Invest New Drugs 23 (2005) 411-415